1. Nathan DM, Buse JB, Davidson MB et al.Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. Diabetes Care2008;31:1–11.
2.
1. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med2005;353:2643–53.
3.
2. UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet1998;352:837–53.
4.
3. The ADVANCE Collaborative Group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med2008;358:2560–72.
5.
4. The Action to Control Cardiovascular Risk in Diabetes Study Group.Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med2008;358:2545–59.
6.
5. American Diabetes Association Press Release: Intense Blood Glucose Control Yields no Significant Effect on CVD Reduction in VA Diabetes Trial. (Accessed on September 28, 2008 at http://www.diabetes.org/for-media/pr-intense-blood-glucose-control-yields-no-significant-effect-on-cvd-reduction.jsp)
7.
6. Matthews DR, Tsapas A.Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes. Diabetes Vasc Dis Res2008;5:216–18; doi:10.3132/dvdr.2008.035.
8.
7. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW.10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med2008;359:1577–89.
9.
8. UK Prospective Diabetes Study (UKPDS) Group.Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet1998;352:854–65.
